ONVO

Organovo Releases Fiscal Report for Q3 2017; Offers Projections for the Year

As Organovo leads in the realm of 3D printed human tissue, it’s no surprise to see that revenues are up once again—and substantially so. Reporting fiscal results for Q3 2017…

Organovo’s Bioprinting Future Certainly Looks Bright — CEO Keith Murphy Provides Interesting Insight

Even before meeting Keith Murphy for the first time at an Inside 3D Printing Event last year I had been a big fan of the San Diego-based company. And although…

Bursting of The 3D Printing Stock Bubble Vs. Dot-com Bust

Although I was only 18 at the time, only having mildly played around in the stock market, and more worried about getting accepted to a decent college than what the…

Are 3D Printing Stocks Finally Cheap?

First off I’d like to start by saying I have been an investor within the 3D printing sector for a few years now. I’ve held the majority of my shares…

Organovo Explains Why They’ve Raised an Additional $40M – Cites Potential for $400M in Annual Revenue

As we’ve mentioned in the past, the rollercoaster ride, known all too well to Organovo (NYSEMKT: ONVO) shareholders, has been quite bumpy. The stock price has dropped considerably following an announcement…

Organovo Raises an Additional $40M Via Secondary Offering at $4.25 Per Share

If you are an investor, particularly within the 3D printing space, then you know that it often takes nerves of steel to not panic when the stocks you own seem…

Organovo & Merck Enter Multi-year Research Partnership for 3D Printed Human Tissue

The 3D bioprinting space may be about to take off in a big way. As investment dollars flow into companies seeking to transform medicine via the 3D printing of biological…

Organovo Pre-Announces Quarterly & Annual Financial Data to the Market’s Delight

If you hold shares of Organovo stock (NYSE MKT: ONVO), then you know that the past 18 months have been a rollercoaster ride. Shares of the stock have bounced between…

L’Oréal USA & Organovo Team for 3D Printed Human Skin Tissue Research

You all probably know by now that Organovo (NYSE: ONVO) is leading the charge when it comes to 3D printing organ tissue. They have already brought human liver tissue to…

Organovo Presents Data on Fully Cellular 3D Bioprinted Kidney Tissue

Bioprinting is in our future. No longer the stuff of sci-fi dreams, the technology is taking a true hold in today’s world — and even in the dictionary. By bringing…

Organovo and Yale Announce Collaboration on 3D Bioprinting for Organ Transplantion

Without a doubt, the most exciting applications for 3D printing, reside within the medical field. Companies like San Diego-based Organovo (NYSE: ONVO) are making substantial progress within the area of…

exVive3D 3D Printed Human Liver Tissue Now Commercially Available by Organovo

New technologies such as 3D bioprinting promise to offer a laundry list of new treatments, drug discovery, and cures within the medical industry. With that said, we have been hearing…

Organovo Only 4-6 Years Away From 3D Printing Partial Livers For Human Implantation

There are so many areas within the 3D printing space one can get excited about; however, in my opinion one of the most exciting areas is the work being done…

Organovo and Johnson & Johnson Team to Evaluate 3D Bio-printed Tissue Use

It’s only a matter of time before 3D bio-printing really takes off. One of the leaders in the space is Organovo, a company who has already been able to 3D…